Breast Cancer Awareness Month #MammSaidSo
Know MoreTotal experience: 25 years - Blood Banking: 15 years - Worked at NIMHANS Transfusion Medicine Department - Experience working as a GP in Dubai, UAE: 4 years
Certifications
– Advance Certificate in Transfusion
Medicine (Asian Association of
Transfusion Medicine)
– Good Clinical Practice (NIDA Clinical
Trial Networks)
Memberships
– Indian Society of Blood Transfusion
and Immunohematology (ISBTI)
– Indian Medical Association (IMA)
– Red Cross Society of India
Publications
Contributed in paper publications in
Asian Journal of Transfusion Science.
Topics:
-Distribution of ABO and Rhesus-D
blood groups in and around Bangalore.
– Pre-donation deferral of blood donors
in South Indian set-up: An analysis.
Research work
Principal Investigator for below studies
1. Buffy Coat as a Source of Immune Cells in the
manufacturing of Chimeric Antigen Receptor
(CAR) Based Cell & Gene Therapy (CGT)
2. Collection of leukapheresis samples (leukopak)
from healthy donors for creation of CAR-NK
cells for treatment of certain types of cancers
3. Collection of blood samples from healthy
donors for ex-vivo expansion of NK cells for
treatment of early-stage colon cancer
4. Effects of immune check point inhibitors on
T-cell function
Total experience: 25 years - Blood Banking: 15 years - Worked at NIMHANS Transfusion Medicine Department - Experience working as a GP in Dubai, UAE: 4 years
Certifications
– Advance Certificate in Transfusion
Medicine (Asian Association of
Transfusion Medicine)
– Good Clinical Practice (NIDA Clinical
Trial Networks)
Memberships
– Indian Society of Blood Transfusion
and Immunohematology (ISBTI)
– Indian Medical Association (IMA)
– Red Cross Society of India
Publications
Contributed in paper publications in
Asian Journal of Transfusion Science.
Topics:
-Distribution of ABO and Rhesus-D
blood groups in and around Bangalore.
– Pre-donation deferral of blood donors
in South Indian set-up: An analysis.
Research work
Principal Investigator for below studies
1. Buffy Coat as a Source of Immune Cells in the
manufacturing of Chimeric Antigen Receptor
(CAR) Based Cell & Gene Therapy (CGT)
2. Collection of leukapheresis samples (leukopak)
from healthy donors for creation of CAR-NK
cells for treatment of certain types of cancers
3. Collection of blood samples from healthy
donors for ex-vivo expansion of NK cells for
treatment of early-stage colon cancer
4. Effects of immune check point inhibitors on
T-cell function